Blackwell Science, LtdOxford,

UKCHACephalalgia0333-1024Blackwell Science, 2005263290294Original ArticleA sleep study in cluster headacheG Della Marca et al.

doi:10.1111/j.1468-2982.2005.01037.x

A sleep study in cluster headache

G Della Marca1, C Vollono1,2, M Rubino1, A Capuano1, G Di Trapani1 & P Mariotti1
1

Institute of Neurology, Department of Neuroscience, Catholic University and 2Fondazione Pro Juventute Don C. Gnocchi, Rome, Italy

Della Marca G, Vollono C, Rubino M, Capuano A, Di Trapani G & Mariotti P. A sleep study in cluster headache. Cephalalgia 2006; 26:290294. London. ISSN 03331024 Cluster headache (CH) is a primary headache with a close relation to sleep. CH presents a circa-annual rhythmicity; attacks occur preferably during the night, in rapid eye movement (REM) sleep, and they are associated with autonomic and neuroendocrine modications. The posterior hypothalamus is the key structure for the biological phenomenon of CH. Our aim is to describe a 55-year-old man presenting a typical episodic CH, in whom we performed a prolonged sleep study, consisting of a 9-week actigraphic recording and repeated polysomnography, with evaluation of both sleep macrostructure and microstructure. During the acute bout of the cluster we observed an irregular sleepwake pattern and abnormalities of REM sleep. After the cluster phase these alterations remitted. We conclude that CH was associated, in this patient, with sleep dysregulation involving the biological clock and the arousal mechanisms, particularly in REM. All these abnormalities are consistent with posterior hypothalamic dysfunction. Actigraphy, arousal, cluster headache, polysomnography, posterior hypothalamus, sleep Giacomo Della Marca, Institute of Neurology, Department of Neuroscience, Catholic University, L.go Gemelli, 8-00168, Rome, Italy. Tel. + 39 06 3015 4276, fax + 39 06 3550 1909, e-mail dellamarca@rm.unicatt.it Received 16 April 2005, accepted 23 May 2005

Introduction
Cluster headache (CH) is a primary headache (1) of neurovascular origin (2). Clinically, episodic CH is characterized by a very severe pain, always unilateral and usually retro-orbital, associated with restlessness or agitation and autonomic symptoms (2). The attacks of CH occur typically in bouts (clusters) of a few months. The rhythmic course, the autonomic activation, the circadian biological rhythmic changes and the neuroendocrine disturbances (3), in particular involving melatonin (4), have suggested a pivotal role for the hypothalamus which has been demonstrated by functional neuroimaging with positron emission tomography (5) and by anatomical imaging with voxel-based morphometry (6). Clusters have a half-yearly, yearly or even biennial periodicity (7). Within a CH cluster about 50% of attacks occur at night, and in the same individual they often occur at the same hour each day (7). CH is closely related to sleep (8). Wolff (9) observed that the majority of cluster headaches occur during sleep, with pain that startles the patient from bed. Dexter
290

and Weitzmann (10) rst reported that episodic attacks of CH tend to occur during rapid eye movement (REM) sleep; these data have been conrmed (11) and recently (12, 13) CH attacks have been observed during REM sleep, following haemoglobin desaturations. The aim of the present study was to investigate the sleep pattern of a patient with typical episodic CH during a cluster and in the pain-free interval. We used wrist actigraphy to investigate circadian sleep wake cycles, polysomnography (PSG) to analyse sleep structure and to observe in which sleep stage pain occurred; also, an analysis of sleep microstructure was made to investigate the relation between CH and arousal.

Case report
A 55-year-old man presented with episodic CH since the age of 50 years. The typical attacks consisted of a very severe (10/10) pricking pain in the right retroorbital and right temporal areas. The pain was associated with photophobia. Cluster periods occurred
Blackwell Publishing Ltd Cephalalgia, 2005, 26, 290294

A sleep study in cluster headache once per year and lasted 34 weeks. During the cluster, attacks occurred twice per day, each attack lasting 4590 min, and most of them (more than one half) awakened the patient from night sleep. During the attacks he had tearing, ipsilateral conjunctival injection and eyelid oedema; the right nostril was congested. At the moment of our rst observation the patient was in the cluster period, which had begun 12 days before. His physical and neurological examinations were normal. Brain magnetic resonance imaging was normal. Prophylactic treatment was started with gabapentin up to 900 mg/day; gabapentin was chosen because EKG documented a sinusal bradicardia (4550 beats/min), which contraindicated the administration of verapamil. Subcutaneous sumatriptan injections (6 mg) for the treatment of pain attacks were administered on two occasions. Prophylaxis was immediately effective in reducing the frequency, duration and severity of attacks. On a follow-up visit the patient reported that these episodes ceased after a period of 3 weeks. As concerns the sleepwake habits, the patient did not complain of any sleep disorder before, during or after the cluster episode. The patient gave his written informed consent to enter the study.

291

comparisons, with an adjusted signicance level of 0.00625.

Polysomnography
Three full-night ambulatory polygraphic recordings (EEG, EOG, EMG) were performed, each lasting 48 consecutive hours, in order to allow the patient to sleep in his home setting and to keep his natural sleepwake schedule. The rst study was performed before starting the treatment (nights 1 and 2), the second during the treatment (nights 3 and 4), the third during remission, after drug withdrawal (nights 5 and 6). Sleep analysis was performed according to the criteria of Rechtschaffen and Kales (18), and, for the arousals, to the rules of the American Sleep Disorders Association (ASDA) (19).

Results Cardiorespiratory monitoring

MESAM 4 ruled out the presence of any signicant oxygen desaturation during sleep.

Actigraphy
Figure 1 shows three actograms, two referring to the cluster period (Fig. 1A,B) and one referring to the remission period (Fig. 1C). Several attacks of CH occurred during the recordings. Actigraphic recordings revealed that the patients sleepwake schedule was irregular during the CH period and progressively modied, becoming more regular, after remission. In particular, the interdaily variability index (19) was 0.513 and 0.545 in the rst two recordings, and rose to 0.681 in the recording after remission. Several episodes of diurnal sleep (naps) were observed in the cluster periods; napping was almost completely absent in the remission period. As concerns the statistical comparison among conditions (C = cluster period, R = remission period), we observed a signicant decrease of actual sleep time (AST) (average AST C = 376 74 min; R = 350 61 min; P = 0.0040) and sleep efciency index (SEI) (average SEI C = 73.1 6.8%; R = 67.6 7.8%; P = 0.0051). By contrast, we observed a signicant increase in mean activity score (MAS) (average MAS C = 20.32 4.22; R = 24.66 6.81; P = 0.0027) and fragmentation index (FI) (average FI C = 53.30 22.77; R = 73.15 28.71; P = 0.0002). No signicant difference between the two conditions was found in time in bed (P = 0.0558), sleep latency (P = 0.6017), assumed sleep duration (P = 0.0134) and wake time (P = 0.8529).

Methods
Sleep study included: (i) cardiorespiratory monitoring; (ii) actigraphy; and (iii) PSG.

Cardiorespiratory monitoring
A one-night polygraphic recording was performed with MESAM 4 (14) in order to rule out obstructive sleep apnoea syndrome (12, 13).

Actigraphy
Actigraphy was performed to evaluate the circadian rhythms of sleep and wake. Three separate recordings were performed, each lasting three consecutive weeks. The rst recording started at the moment of our rst observation, 12 days after the onset of the cluster period; the second was performed during pharmacological treatment (7 weeks after the onset); the third was performed during follow-up, 3.5 months after the last attack and 2.5 months after drug withdrawal. Actigraphic monitoring was performed in agreement with guidelines reported in the literature (1517). Data from the single nights in the two conditions (cluster period and remission) were compared by two-tailed unpaired Students t-test followed by Bonferroni correction for multiple
Blackwell Publishing Ltd Cephalalgia, 2005, 26, 290294

292

G Della Marca et al.

18.00 h 00.00 h 06.00 h 12.00 h 12.00 h 18.00 h 00.00 h 06.00 h 12.00 h 12.00 h
PSG 5 PSG 6 GP 600 mg

12.00 h
PSG 1 PSG 2

18.00 h

00.00 h

06.00 h

12.00 h

GP 900 mg

Patient wore off actigraph

PSG 3 PSG 4 B C

Figure 1 Actograms from the three recordings, each lasting three consecutive weeks. (A,B) Cluster period. (C) Remission period. The upper horizontal bar indicates time of day. Arrows indicate the days in which cluster headache attacks occurred. Days when polygraphic (PSG) recordings were performed are specied on the left of the actogram. GP, Gabapentin. Start of treatment and dose modication are specied on the right side of the actogram. Table 1 Polysomnography (PSG) parameters PSG parameters Macrostructure Sleep onset latency, min Total sleep time, min Sleep period time, min Sleep efciency, % Number of REM periods REM latency, min Sleep stage percentages REM, % Stage 1, % Stage 2, % Stage 3, % Stage 4, % Wake parameters Total number of awakenings Awakenings > 2 min Wake after sleep onset, min Arousals Arousal index in total sleep, events/h Arousal index in NREM, events/h Mean arousal duration NREM, s Arousal index in REM, events/h Mean arousal duration REM, s PSG 1 PSG 2 PSG 3 PSG 4 PSG 5 PSG 6

2.0 548 601 91.0 5 54 25.1 10.4 33.7 13.1 7.4 16 3 59.5 11.7 12.02 12.3 6.9 5.56 14.1 3.9

4.5 545 588 92.2 5 63 20.3 7.1 43.6 14.5 6.0 33 5 48.5 11.0 9.69 12.7 6.3 3.58 19.8 3.2

20.0 590 639 91.6 7 65 16.6 5.7 50.8 11.6 6.7 32 9 95.5 11.2 7.08 16.1 10.8 12.45 15.6 10.9

5.5 659 709 92.8 8 72 20.6 4.0 42.2 19.3 6.7 21 9 56.0 13.9 7.95 16.1 10.1 13.02 14.9 10.9

10.0 466 537 86.6 6 51 16.1 15.5 36.0 11.0 7.6 33 10 72.5 13.3 11.13 11.1 7.0 15.00 13.6 6.5

2.5 413 447 91.8 4 56 13.6 8.9 31.8 18.7 18.0 26 7 40.0 13.7 8.95 17.2 5.7 12.79 13.8 7.4

Sleep period time, interval between sleep start and sleep end; Sleep efciency, percentage of time spent asleep whilst in bed. Sleep stages percentages are calculated on sleep period time.

Polysomnography
The main results of polygraphic recordings are listed in Table 1, and hypnograms are shown in Fig. 2. Headache attacks occurred during recordings 1 and 2; both occurred during REM. Both attacks were

treated successfully with sumatriptan and the patient returned to sleep. PSGs performed in the cluster period conrmed the great variability in sleep duration observed with actigraphy. PSGs 5 and 6, after remission, showed slightly shorter sleep duration, and a reduction of the total amount of
Blackwell Publishing Ltd Cephalalgia, 2005, 26, 290294

A sleep study in cluster headache

Attack
REM Wake
1 2 3 4 Time

293

00:00 h

06:00 h

REM Wake
1 2 3 4 Time

Attack

00:00 h

06:00 h

REM Wake
1 2 3 4 Time

00:00 h

06:00 h

REM Wake

1 2 3 4 Time 00:00 h

06:00 h

REM Wake
1 2 3 4

00:00 h

06:00 h

REM Wake
1 2 3 4

00:00 h

06:00 h

Figure 2 Sleep stage histograms (hypnograms) in the six nights of polysomnographic recording. On the left of the hypnograms sleep stages are indicated (REM, rapid eye movement sleep; 1, stage 1 NREM; 2, stage 2 NREM; 3, stage 3 NREM; 4, stage 4 NREM); the lower horizontal bar indicates time. Grey arrows mark headache attack onset.

REM (in minutes) and of REM percentages. No modication of the arousal parameters across the recordings was observed, except for arousal index in REM. This index was much lower in the rst two nights, those with attacks (index = 5.56 and 3.58 events/h of REM sleep), than in the remaining four (12.45, 13.02, 15.00, 12.79 events/h of REM sleep).

Discussion
CH induced relevant modications of the sleep wake pattern of our patient. During the cluster period, actigraphy showed an irregular sleepwake cycle, characterized by high interdaily variability, inconstant sleep duration, repeated nocturnal awakenings and frequent daytime napping (Fig. 1A,B). When the cluster period ended and gabapentin was withdrawn (Fig. 1C), the sleepwake pattern appeared fully normalized. This indicates that the cluster period was associated with a transient dysfunction of the biological clock. Alternatively, the irregular sleepwake cycle could be a consequence of pain (20). The latter interpretation is not consistent with the observation that a marked interdaily variability of the sleepwake rhythm still persisted even
Blackwell Publishing Ltd Cephalalgia, 2005, 26, 290294

when headache attacks were controlled by gabapentin. Therefore, we believe that the sleepwake pattern dysregulation observed in our patient is a specic clinical feature of the CH. This is consistent with previous data in literature, which documented that CH is a chronobiological disorder (7), due to hyperactivation of the posterior hypothalamus (5, 6, 21). PSGs conrmed the variability in sleepwake schedule observed with actigraphy. As regards the PSGs, the most relevant ndings concern REM sleep. Two severe attacks occurred in REM at the beginning of the night. Besides, during the cluster, REM episodes were fragmented, and interspersed by periods of NREM sleep. After remission, REM sleep time and REM percentages and REM fragmentation were reduced (Fig. 2). Therefore, PSG ndings suggest some dysregulation of the ultradian NREM/REM cyclicity within sleep in this patient. At a microstructural level, the arousal index calculated in REM was much lower in the rst two nights, in which attacks occurred. An effect of sumatriptan cannot be ruled out, but it seems unlikely, since arousal modications involved REM sleep. Alternatively, we may speculate that REM sleep in the

294

G Della Marca et al.

10 Dexter JD, Weitzman ED. The relationship of nocturnal headaches to sleep stage patterns. Neurology 1970; 20:513 8. 11 Jennum P, Jensen R. Sleep and headache. Sleep Med Rev 2002; 6:4719. 12 Chervin RD, Zallek SN, Lin X, Hall JM, Sharma N, Hedger KM. Sleep disordered breathing in patients with cluster headache. Neurology 2000; 54:23026. 13 Nobre ME, Leal AJ, Filho PMF. Investigation into sleep disturbance of patients suffering from cluster headache. Cephahalgia 2005; 25:48892. 14 Stoohs R, Guilleminault C. MESAM 4: an ambulatory device for the detection of patients at risk for obstructive sleep apnea syndrome (OSAS). Chest 1992; 101:12217. 15 Sadeh A. Actigraphically based automatic bedtime-sleepwake validation and clinical application. J Ambulatory Monitoring 1989; 2:20916. 16 Bruni O, Russo PM, Violani C, Guidetti V. Sleep and migraine: an actigraphic study. Cephalalgia 2004; 24:134 9. 17 Van Someren EJ, Swaab DF, Colenda CC, Cohen W, McCall WV, Rosenquist PB. Bright light therapy: improved sensitivity to its effects on restactivity rhythms in Alzheimer patients by application of nonparametric methods. Chronobiol Int 1999; 16:50518. 18 Rechtschaffen A, Kales A. A manual of standardised erminology, techniques and scoring system for sleep stages of human subjects. Los Angeles: Brain Information Service/ Brain Research Institute, UCLA 1968. 19 American Sleep Disorders Association. EEG arousals: scoring rules and examples. Sleep 1992; 15:17484. 20 Paiva T, Batista A, Martins P, Martins A. The relationship between headaches and sleep disturbances. Headache 1995; 35:5906. 21 Sanchez del Rio M, Alvarez Linera J. Functional neuroimaging of headaches. Lancet Neurol 2004; 3:64551. 22 Gder S, Fritzer G, Kapsokalyvas A, Kropp P, Niederberger U, Strenge H et al. Polysomnographic ndings innights preceding a migraine attack. Cephalalgia 2001; 21:317. 23 Strenge H, Fritzer G, Goeder R, Niederberger U, Gerber WD, Aldenhoff A. Non-linear electroencephalogram dynamics in patients with spontaneous nocturnal migraine attacks. Neurosci Lett 2001; 309:1058. 24 Coppola G, Vandenheede M, Di Clemente L, Ambrosini A, Fumal A, De Pasqua V, Schoenen J. Somatosensory evoked high-frequency oscillations reecting thalamocortical activity are decreased in migraine patients between attacks. Brain 2005; 128:98103. 25 Sahota PK, Dexter JD. Transient recurrent situational insomnia associated with cluster headache. Sleep 1993; 16:2557. 26 Isik U, DCruz OF. Cluster headaches simulating parasomnias. Pediatr Neurol 2002; 27:2279. 27 Jones BE. Arousal systems. Front Biosci 2003; 1 (8):s43851. 28 McGinty D, Szymusiak R. Brain structures and mechanisms involved in the generation of NREM sleep: focus on the preoptic hypothalamus. Sleep Med Rev 2001; 5:32342. 29 Suntsova NV, Dergacheva OY, Burikov AA. The role of the posterior hypothalamus in controlling the paradoxical phase of sleep. Neurosci Behav Physiol 2000; 30:1617.

acute bout of the cluster is associated with a condition of hypoarousability. Also, the reduced motor activity during sleep shown by actigraphy in the cluster period is consistent with hypoarousability. Hypoarousal is a pathogenic mechanism in migraine (2224); impaired arousal activity during CH has been suggested (25, 26). The posterior hypothalamus has a role in the arousal mechanisms, since it projects directly to the cerebral cortex, and its stimulation elicits a cascade of arousal responses, including cortical activation, motor activity and sympathetic responses (27). The posterior hypothalamus also plays a crucial role in the inhibitory control of the executive mechanisms of paradoxical sleep (28, 29). In conclusion, we believe that in our patient the CH induced an acute, transient, global modication of sleep regulation, at several levels. These levels included the circadian sleepwake rhythmicity, the macrostructural pattern of NREM/REM ultradian cycle, and also the sleep microstructure, that is to say the dynamics of arousal; this latter abnormality selectively involved REM sleep. All the observed modications are consistent with an abnormal function of the posterior hypothalamus.

References
1 Headache Classication Committee of the International Headache Society. The international classication of headache disorders, 2nd edition. Cephalalgia 2004; 24 (Suppl. 1):1151. 2 Goadsby PJ. Pathophysiology of cluster headache: a trigeminal autonomic cephalalgia. Lancet Neurol 2002; 1:2517. 3 Leone M, Partuno G, Vescovi A, Bussone G. Neuroendocrine dysfunction in cluster headache. Cephalalgia 1990; 10:2359. 4 Leone M, Lucini V, DAmico D, Grazzi L, Moschiano F, Fraschini F, Bussone G. Abnormal 24-hour urinary excretory pattern of 6-sulphatoxymelatonin in both phases of cluster headache. Cephalalgia 1998; 18:6647. 5 May A, Bahra A, Buchel C, Frackowiak RSJ, Goadsby PJ. Hypothalamic activation in cluster headache attacks. Lancet 1998; 351:2758. 6 May A, Ashburner J, Buchel C, McGonigle DJ, Friston KJ, Frackowiak RS, Goadsby PJ. Correlation between structural and functional changes in brain in an idiopathic headache syndrome. Nat Med 1999; 5:8368. 7 Dodick DW, Eross EJ, Parish JM, Silber M. Clinical, anatomical, and physiologic relationship between sleep and headache. Headache 2003; 43:28292. Erratum in: Headache 2004; 44:384. 8 Russell D. Cluster headache: severity and temporal prole of attacks and patient activity prior to and during attacks. Cephalalgia 1981; 1:20916. 9 Wolff HG, editor. Headache and other head pain, 2nd edn. New York: Oxford University Press 1963:150.

Blackwell Publishing Ltd Cephalalgia, 2005, 26, 290294